novel keap1/nrf2 target gene regulating ferroptosis and radioresistance in lung cancers | oncotarget
Published 2 years ago • 645 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
4:09
stk11/ keap1 co-mutant lung adenocarcinoma is dependent on scd1 to evade ferroptosis
-
1:43
loss of function mutations in keap1 drive lung cancer progression
-
27:39
novel therapeutics in ovarian cancer: what to watch
-
1:09
current and novel treatment approaches for first-line egfr-m nsclc
-
3:57
novel kinase inhibitor promising in nsclc
-
30:45
novel non immunotherapy targets and agents in gastroesophageal cancer
-
0:45
dr. hamilton on using pcr to classify risk in her2 breast cancer
-
30:45
novel non-immunotherapy targets and agents in gastroesophageal cancer
-
58:26
novel therapeutic approach to lethal sars cov 2 infection in aged murine models
-
6:13
case 2: cdk4/6 inhibitor recommendations in er breast cancer
-
5:35
case 2: treatment recommendations for er breast cancer
-
4:01
mechanisms and prospects of a novel cdk9 inhibitor
-
6:05
mechanisms of resistance to parp inhibitor or platinum chemotherapy in brca1/2 mutated metastati...
-
2:40
novel therapies on the horizon for lung cancer
-
4:20
novel treatment strategies in r/r multiple myeloma
-
2:15
phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
25:10
life after 1st line targeted therapy: what next?